Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
37.5%
% of HRTS's 40 holdings also in WDNA
17.9%
% of WDNA's 90 holdings also in HRTS
Overlap by Weight
Sector Drift (HRTS minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.1% | 2.7% | 2.7% |
|
BRIDGEBIO PHARMA, INC. | 4.2% | 2.4% | 2.4% |
|
GILEAD SCIENCES INC | 3.1% | 1.9% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 3.4% | 1.8% | 1.8% |
|
AMGEN INC | 1.8% | 1.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to WDNA
|
ELI LILLY & CO | 7.4% |
|
UNITEDHEALTH GROUP INC | 6.0% |
 |
ASTRAZENECA PLC | 4.1% |
 |
NOVO NORDISK A/S-B | 3.9% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 3.9% |
|
ABBOTT LABORATORIES | 3.8% |
|
BOSTON SCIENTIFIC CORP | 3.0% |
 |
MEDTRONIC PLC | 3.0% |
|
CRINETICS PHARMACEUTICALS INC | 2.6% |
|
ABBVIE INC | 2.4% |
HRTS Underweight Relative to WDNA
|
NATERA INC | -3.7% |
|
TWIST BIOSCIENCE CORP. | -3.3% |
|
NOVOZYMES A/S-B SHARES | -2.9% |
|
VERICEL CORPORATION | -2.6% |
|
BLUEPRINT MEDICINES CORP. | -2.6% |
|
VERACYTE INC | -2.1% |
|
AGIOS PHARMACEUTICALS INC | -1.9% |
|
UNITED THERAPEUTICS CORP | -1.7% |
|
LABCORP HOLDINGS | -1.5% |
|
DUPONT DE NEMOURS INC | -1.5% |